Cardiovascular Drugs and Therapy

Congestive Heart Failure and Genomic Medicine: A Look into the 21st Century
pp. 713-717(5)
Authors: Feuerstein G.Z.; Ruffolo Jr. R.R.

New Developments in Cardiovascular Drugs: Vitamin E and Antioxidants—An Informal and Personal Viewpoint
pp. 719-721(3)
Author: Opie Editor L.H.

T-Type Ca^2+ Channels and Pharmacological Blockade: Potential Pathophysiological Relevance
pp. 723-739(17)
Authors: Ertel S.I.; Ertel E.A.; Clozel J-P.

Verapamil Normalizes the Response of Left Ventricular Early Diastolic Filling to Cold Pressor Test in Asymptomatic and Mildly Symptomatic Patients with Hypertrophic Cardiomyopathy
pp. 741-746(6)
Authors: Dimitrow P.P.; Surdacki A.; Dubiel J.S.

Effects of Monatepil, a Novel Calcium Antagonist with _1-Adrenergic Blocking Activity, on the Low-Density Lipoprotein Receptor in Human Skin Fibroblasts
pp. 747-750(4)
Authors: Matsunaga A.; Inoue T.; Koga T.; Mori K.; Kugi M.; Sasaki J.; Arakawa K.

Bradycardia Induced by Mivazerol, a Selective _2-Adrenoceptor Agonist, Is Amplified During Mild Hypothermia in the Pentobarbital-Anesthetized Rat
pp. 751-755(5)
Authors: Kim S.Y.; Raikoff K.; Wülfert E.; Hanin I.

Nicorandil Improves Ischemic Changes in Epicardial ECG During Short-Term Coronary Occlusion by Opening ATP-Sensitive Potassium Channels in Pigs
pp. 757-766(10)
Authors: Takaoka A.; Nakae I.; Liu Q.; Yamamoto K.; Ito M.; Kinoshita M.

Different Effects of Flecainide on Atrioventricular Conduction Properties in the Adult and Immature Rabbit Heart
pp. 767-776(10)
Authors: Han H-S.; Hewett K.W.; McKay C.A.; Gillette P.C.; Case C.L.

A New Platelet-Activating Factor Antagonist (CV-6209) in Preservation of Heart and Lung for Transplantation
pp. 777-785(9)
Authors: Qayumi K.A.; English J.C.; Feeley E.J.E.; Poostizadeh A.; Nikbakht-Sangari M.

Short-Term Treatment with Low-Dose Pravastatin Attenuates Oxidative Susceptibility of Low-Density Lipoprotein in Hypercholesterolemic Patients
pp. 787-793(7)
Authors: Chen M-F.; Hsu H-C.; Lee Y-T.

Effect of Hypotensive Drugs on the Circadian Blood Pressure Pattern in Essential Hypertension: a Comparative Study
pp. 795-799(5)
Authors: Zakopoulos N.; Stamatelopoulos S.; Moulopoulos S.

Neuropeptide Y Y1 Receptor Antagonist (BIBP 3226) Attenuates Stress Evoked Tachycardia in Conscious Spontaneously Hypertensive Rats
pp. 801-806(6)
Authors: Zhang W.; Lundberg J.M.; Thorén P.